MicrobioTx launches IBS Risk Score to enable early detection of gut disorder
The launch coincides with IBS Awareness Month in April
The launch coincides with IBS Awareness Month in April
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Revvity is positioning its technologies as a connected engine for discovery
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
The company reported net revenue of SEK 13.5 million for the full year 2025
Subscribe To Our Newsletter & Stay Updated